Dissecting Insulin Price Policy and Misinformation

In 2020, California became the first to take a novel approach with a new law allowing the state to develop its own generic versions of medications, including insulin. The state is now able to contract with existing manufacturers to produce lower-cost drugs, and it is possible that the grassroots researchers at Open Insulin in Northern California may be able to participate in this effort. Time will tell.

These are great moves forward at the state level, even as federal policy changes are being announced but not yet implemented. Meanwhile, other efforts continue to help PWDs in need get the insulin they need. See the new Beyond Type 1 program GetInsulin.org, which is a sort of clearinghouse for manufacturer-offered savings programs.

Gradually but surely, help is on the way for people whose lives depend on insulin.